ABSTRACT
INTRODUCTION
Chronic liver disease was involving a progressive destructive and regenerative process that begins and hepatocellular carcinoma. Liver fibrosis was caused by chronic damage in liver tissue, related to abundant accumulation of extracellular matrix (ECM) protein. 1, 2 infection of Hepatitis B and C virus, alcoholism, autoimmune disease, cholestatic disease, and nonalcoholic steatohepatitis (NASH). Accumulation of ECM protein will damage liver architecture by of liver nodule. A well-formed nodule stage was also known as liver cirrhosis. 2 healing process in response to chronic liver tissue injury. Liver cirrhosis detection and staging were important in chronic hepatitis patient management. 2 Chronic Hepatitis B was the most common infection in chronic hepatitis worldwide. A predictive model patients by Shanghai Liver Fibrosis Group (SLFG), Hui et al, and Mohamadnejad et al. 3, 4 However, only several of models above that have been validated and implemented in clinical situation. 3, 4 problem that lead to high morbidity and mortality in needed to determine the suitable early treatment. 5 Liver biopsy as an invasive method was still become the problem was that clinical presentation of the disease was vary among patients and not always similar to its degree, besides that several patients also refused biopsy procedure. 5 Limitation in biopsy procedure was variation among biopsy result of both intra and interobserver, and also a sampling error. There were also degree groups. 6,7 5 There were a lot of research to develop any noninvasive predictive model that strongly correlate to invasively. 4, 5, 8 This technique was known as ultrasound elastography, commercially known as Fibroscan. This new imaging technique has been proven to assess liver fibrosis degree with high accuracy. 4, 8 a routine test in clinical practice. This instrument kilopascal unit (kPa). 4, 8 stages. This diagnostic accuracy of FibroScan was also higher compared to several biochemistry markers examination. The advantage of FibroScan was that it is done in a short time periode, without any pain, and less misinterpretation risk compared to liver biopsy. 4, 7, 8, 9 There has been previous study to investigate the in compared to Fibroscan in chronic Hepatitis C patients. 10 Therefore, we aimed to investigate the Hepatitis B infection based on King's score compared to FibroScan, as a daily clinical reference for chronic Hepatitis B patients. To measure its diagnostic value, receiving operating characteristic (ROC) curve was used to assess its value (PPV), negative predictive value (NPV), diagnostic accuracy (DA), positive likelihood ratio (LR+), and negative likelihood ratio (LR-) based on cut off value in its original journal. Analysis was done using SPSS ver 15 software.
RESULTS
Overall, a total of 62 chronic Hepatitis B patients was involved in this study. Clinical characteristic, was further evaluated using area under ROC curve (AUROC), LR (+), LR (-), and diagnostic accuracy. In 4). Form this result, although only consist of routine laboratory examination, King's score was accurate and well-predictive in cirrhosis prediction. and accuracy value of this predictive model was shown in Table 2 . In Table 2 , King's score showed a high predictive value to predict liver cirrhosis, and also a high sensitivity, high NPV, and low LR (-) so that it has lower false negative incidence. Result in King's 76,5% PPV, 68,9% NPV, 0,54 LR (+), 0,53 LR (-), 
DISCUSSION
There were several previous non-invasive diagnostic model in chronic Hepatitis that have been published. Most of those diagnostic model was used in chronic Hepatitis C patients and only a few in chronic Hepatitis B patients. 11 Although two last study of FibroTest in chronic Hepatitis B patients showed a 0,77 and 0,78 in AUROC value, those model was using unroutine laboratory examination, such as haptoglobin, A2M, and apolipoprotein A1. Its complexity and cost reduce its utility in daily practice. 12 Several predictive model that design for chronic Hepatitis B patients was already proposed, but this study was still have several unique factors. First, SLFG model was designed and validate only for HBeAg positive patients with ALT between 2 and 10 times from upper limit of normal (ULN), while Mohamadnejad et al proposed a formula that only suitable for HBeAg negative patients. 11 Hui et al only recruited patients with HBV DNA > 10 5 copy/mL and ALT between 1,5 and 10 from upper limit of normal. In current study, patients recruited was all patients with chronic Hepatitis B without considering its treatment, HBeAg level, ALT, and HBV DNA level. Therefore, this study result was more applicable for chronic Hepatitis B patients with wider coverage. 10, 12, 13 Second, this predictive model of King's score was based in routine laboratory examination. Platelet count, AST, and INR was a routine test that available widely in clinical settings, so there were no need of extra laboratory examination. 10, 11, 12, 13 Previous study by Kun Zhou et al showed that accuracy of diagnostic test such as HA and A2M showed that SLFG model and Hepascore was better in identify significant was insignificant for advanced fibrosis and liver cirrhosis. 12, 14, 15, 16, 17 process. Otherwise, unroutine test in daily practice was reduce its utility for standardization, validation, 14 Third, King's score was easy to calculate. Several previous model, except APRI, consist of complex formula that need a calculator in algoritm calculation. 9, 12 This simplicity of King's score and APRI showed that it is clinically easier to be applied. But, APRI that previously investigated in chronic Hepatitis C patients having one of its indicator, AST, to be proven B patients, according to Kun Zhou et al. 12 This was the explanation why APRI has a lower AUROC compared to King's score. 9, 12 On the other hand, there were several limitations in this study. In this study, not all patients was undergo on FibroScan (transient elastography), although, not shown in this report, ten patients was undergo liver biopsy with similar result to FibroScan result. 8 In Kun Zhou et al, liver biopsy is one of their limitation too by explaining that liver biopsy was not the gold standard because of the possibility in sampling error and observer variability. A prospective analysis result was also claimed that the risk of liver biopsy failure was > 7 times higher than any diagnostic marker. 8, 12, 18 To reduce variability and subjectivity, the use of laparoscopic biopsy, FibroScan, or validating non-invasive test could help the reliability of liver biopsy as gold standard. Other limitation is that this study result was validate in the same population and in small coverage population.
In Asia countries, chronic Hepatitis B was the majority of all chronic liver disease. The main purpose identify eligble patients for antiviral therapy. 19 Based Management, liver biopsy was indicated for patients aged > 40 years with ALT < 2x ULN and HBV DNA > 20.000 IU/mL (HBeAg-positive) or > 2000 IU/mL was the main candidate for antiviral therapy. Based on that guideline, if a candidate have been undergo FibroScan, liver biopsy could be skipped. In patients with normal ALT and FibroScan result < 6,0 kPa, no therapy was indicated, < 7,5 kPa was observed, and > 12 kPa should be considered to received therapy. 4, 15, 19 Although most of non-invasive predictive model could not accurately assess liver fibrosis degree those predictive model was having a good accurate predictive model was to reduce liver biopsy procedure but not for totally replace liver biopsy. 11, 12, 13, 14 Using optimized cut-off core form King's score, it is expected that further livver biopsy needs wa reduced. Furthermore, a combination of several predictive model and invasive diagnostic technique could bring this diagnostic tools into higher level. 10 Combination of both FibroScan and King's score was an intersting method in chronic Hepatitis B patients management. But it has been known that, in daily clinical practice, priority should be given into model that have been validate in large scale study, because of its accuracy could be interfered by different etiologies, populations, and methods.
10,12

CONCLUSION
King's score has the ability to predict cirrhosis high accuracy, so that patients with King's score > 16,7 did not need to undergo liver biopsy. Otherwise, for result. King's score as non-invasive predictive model for liver cirrhosis in chronic Hepatitis B patients have a high accuracy. A further study was needed to validate this result in a larger scale with different population.
